Grants and Contributions

Cystic Fibrosis Canada has since its beginnings, funded high-quality CF research by Canadian researchers from across the country. We’ve always had the goal to fund the best research that will help advance our understanding of the disease and improve the lives of people with cystic fibrosis. The specific research topics were generally directed by the research interests of the scientists themselves, and by their ability to communicate well the need to fund their particular research questions.

The specific objectives of this funding opportunity are:
• To provide recognition and funding to academic researchers;
• To provide a reliable supply of highly skilled and qualified researchers.

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• CIHR-IG will provide funding for applications that are determined to be relevant to its mandate:
o The Institute of Genetics (IG) supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries

• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada's Pan-Canadian STBBI Framework for Action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations identified by Canada's Pan-Canadian STBBI Framework for Action is highly encouraged.
• In alignment with CIHR’s commitment to equity, diversity and inclusion (EDI) in the research system, the RI champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.

• The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH), will provide bridge funding for an application by a mid-career researcher that is relevant to the Institute's mandate:
o As a lifecycle-based Institute, IHDCYH has a broad mandate that covers defined time periods and a wide range of issues pertaining to human development: pre-conception; fertilization; embryonic and fetal development; the health of the mother and father; and the health and development of infants, children and youth.
• Bridge funding can be used at the NPAs discretion to catalyze work on their proposed project in the manner they feel best moves forward their research program, for example, collection of pilot data, demonstration of feasibility, or work to address peer review comments.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to its mandate and research priority areas as described below:
o IMHA Mandate:
¿ IMHA is mandated to provide research leadership related to: active living, mobility and the wide range of conditions related to bones, joints, muscles, connective tissue, skin as well as the mouth, teeth and craniofacial region.
o Research Priority Areas:
¿ Myalgic Encephalomyelitis (ME)
¿ Pain
¿ Oral Health

• This prize was established to recognize the excellence of cancer research being conducted in Canada. This Prize will be given annually to the highest ranking Early Career Researchers in the Project Scheme competitions that fall within the Institute of Cancer Research (ICR) mandate:
o ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.